The Journal of Organic Chemistry
Article
(CDCl3): δ 191.4, 153.6, 153.1, 143.9, 139.4, 138.9, 138.6, 138.4,
138.2, 135.5, 135.4, 134.3, 132.2, 131.7, 128.9, 128.7, 128.4, 128.1,
128.0, 127.9, 127.7, 118.5, 116.7, 114.5, 112.0, 100.9, 100.4, 84.4, 84.3,
67.8, 67.4, 61.4, 25.4, 25.3, 25.2, 25.1, 15.6. MS (TOF MS ES+, m/z):
(M + Na+), 540.3. HRMS (TOF MS ES+, m/z): calcd for
C30H36BNO6Na (M + Na+) 540.2533, found 540.2532.
0 °C, and sodium borohydride (0.16 g, 4.3 mmol, 1.3 equiv) was
added. The resulting mixture was warmed to 25 °C, and after being
stirred at 25 °C for 12 h, the solution mixture was diluted with
saturated aqueous ammonium chloride solution (20 mL). The biphasic
solution was extracted with dichloromethane (4 × 20 mL), and the
combined organic layers were washed with brine (1 × 20 mL) and
dried over sodium sulfate. The sodium sulfate was removed by
filtration, and the solution was concentrated by rotary evaporation.
The residue was purified using silica gel flash column chromatography
(3% methanol in benzene, increasing to 10% methanol) to afford 4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl 4-(hydroxymethyl)-
phenylcarbamate (46; 1.0 g, 2.7 mmol, 84%) as a yellow solid. Mp:
130 °C. IR (cm−1): 3454, 3236, 1726, 1604, 1537. 1H NMR (CDCl3): δ
1.33 (s, 12H), 4.60 (s, 2H), 5.19 (s, 2H), 6.86 (br s, 1H), 7.27 (d, 2H, J =
8.7 Hz), 7.34−7.38 (m, 4H), 7.80 (d, 2H, J = 8.0 Hz). 13C NMR
(CDCl3): δ 153.3, 138.9, 137.1, 136.0, 135.0, 128.2, 127.8, 127.2, 118.8,
83.8, 66.8, 64.8, 24.8. MS (TOF MS ES+, m/z): (M + NH4+), 401.2.
HRMS (TOF MS ES+, m/z): calcd for C21H30BN2O5 (M + NH4+)
401.2248, found 401.2253.
(b). (2S,3S,4S,5R,6S)-Methyl 3,4,5-Triacetoxy-6-(4-((4-((3,7-dime-
thyloct-6- enyloxy)(phenethoxy)methyl)phenylcarbamoyloxy)-
methyl)phenoxy)tetrahydro-2H-pyran-2-carboxylate (35). Reagents:
3 Å molecular sieves (0.30 g), (2S,3S,4S,5R,6S)-methyl 3,4,5-triacetoxy-
6-(4-((4-formylphenylcarbamoyloxy)methyl)phenoxy)-tetrahydro-2H-
pyran-2-carboxylate (34; 30 mg, 52 μmol, 1 equiv), (3,7-dimethyloct-
6-enyloxy)trimethylsilane (42; 23 mg, 0.10 mmol, 2.0 equiv),
trimethyl(phenethoxy)silane (43; 20 mg, 0.10 mmol, 2.0 equiv),
dichloromethane (0.23 mL), and trimethylsilyl trifluoromethanesulfo-
nate (1.8 μL, 0.10 mmol, 0.20 equiv). The product was purified using
silica gel flash column chromatography (20% ethyl acetate in
petroleum ether, increasing to 60% ethyl acetate) to afford
(2S,3S,4S,5R,6S)-methyl 3,4,5-triacetoxy-6-(4-((4-((3,7-dimethyloct-
6-enyloxy)(phenethoxy)methyl)phenylcarbamoyloxy)methyl)-
phenoxy)-tetrahydro-2H-pyran-2-carboxylate (35; 15 mg, 17 μmol,
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl 4-
((Phenoxycarbonyloxy)methyl)phenylcarbamate (12). To a round-
bottom flask was added 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)benzyl 4-(hydroxymethyl)phenylcarbamate (46; 0.20 g, 5.2
mmol, 1 equiv), dichloromethane (2.6 mL), N,N-diisopropylethyl-
amine (0.23 mL, 1.3 mmol, 2.5 equiv), phenyl chloroformate (0.13
mL, 1.0 mmol, 2.0 equiv), and 4-(dimethylamino)pyridine (6.3 mg, 52
μmol, 0.10 equiv). The mixture was stirred at 25 °C for 12 h. The
resulting solution was diluted with saturated aqueous ammonium
chloride solution (1 × 5 mL), and the aqueous layer was extracted
using dichloromethane (2 × 10 mL). The organic extracts were
combined and dried over sodium sulfate. The sodium sulfate was
removed by filtration, and the solution was concentrated by rotary
evaporation. The residue was purified by silica gel flash column
chromatography (10% ethyl acetate in hexanes, increasing to 40%
ethyl acetate) to afford 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzyl 4-((phenoxycarbonyloxy)methyl)phenylcarbamate (12; 0.24
g, 0.48 mmol, 92%) as a white solid. Mp: 88−92 °C. IR (cm−1): 3352,
1
33%) as a waxy white film. The H NMR and 13C NMR spectra likely
contain signals for rotamers, as was observed for compound 26. The
spectra also contain signals for diastereomers. IR (cm−1): 2920, 1750,
1
1610, 1508. H NMR (CDCl3): δ 0.82−1.05 (m, 3H), 1.15−1.91 (m,
13H), 1.92−2.27 (m, 11H), 3.72 (s, 3H), 4.04−4.19 (m, 1H), 4.41 (d,
2H, J = 10 Hz), 4.57 (d, 2H, J = 12 Hz), 5.12−5.14 (m, 3H), 5.18−
5.38 (m, 4H), 5.79−5.90 (m, 1H), 6.63 (br s, 1H), 7.00 (d, 2H, J = 8.0
Hz), 7.13−7.35 (m, 11H). 13C NMR (CDCl3): δ 170.1, 169.3, 169.2,
166.8, 156.6, 153.2, 139.0, 137.6, 131.2, 131.1, 130.0, 128.9, 128.9,
128.2, 127.4, 126.1, 124.7, 118.1, 117.1, 101.0, 99.0, 77.2, 72.6, 71.8,
70.9, 69.0, 66.4, 65.8, 63.8, 53.0, 37.1, 36.6, 36.3, 29.5, 25.7, 25.4, 20.6,
+
20.5, 19.4, 17.6. MS (TOF MS ES+, m/z): (M + NH4 ), 865.4. HRMS
+
(TOF MS ES+, m/z): calcd for C46H61N2O14 (M + NH4 ) 865.4123,
found 865.4097.
Lithium (2S,3S,4S,5R,6S)-6-(4-((4-((3,7-Dimethyloct-6-enyloxy)-
(phenethoxy)methyl)phenylcarbamoyloxy)methyl)phenoxy)-3,4,5-
trihydroxytetrahydro-2H-pyran-2-carboxylate (36). To a round-
bottom flask, cooled to 0 °C, was added (2S,3S,4S,5R,6S)-methyl
3,4,5-triacetoxy-6-(4-((4-((3,7-dimethyloct-6-enyloxy)(phenethoxy)-
methyl)phenylcarbamoyloxy)methyl)phenoxy)tetrahydro-2H-pyran-2-
carboxylate (35; 30 mg, 35 μmol, 1 equiv) and a 0 °C solution of
lithium hydroxide hydrate (8.4 mg, 0.21 mmol, 6.0 equiv) in a mixture
of methanol (2.6 mL), water (1.0 mL), and tetrahydrofuran (0.53
mL). The reaction mixture was stirred for 1 h at 0 °C, at which point
an aliquot of the solution was removed. HPLC analysis was used to
confirm complete deprotection. Methanol and tetrahydrofuran were
removed from the solution by rotary evaporation, and water was
removed by lyophilization to afford lithium (2S,3S,4S,5R,6S)-6-(4-((4-
( ( 3 , 7 - d i m e t h y l o c t - 6 - e n y l o x y ) ( p h e n e t h o x y ) m e t h y l ) -
phenylcarbamoyloxy)methyl)phenoxy)-3,4,5-trihydroxytetrahydro-
2H-pyran-2-carboxylate (36) as a white solid. The product was used
1
2976, 2359, 1727, 1600, 1532. H NMR (CDCl3): δ 1.37 (s, 12H),
5.22 (s, 2H), 5.23 (s, 2H), 6.88 (br s, 1H), 7.10−7.20 (m, 3H), 7.37−
7.42 (m, 8H), 7.85 (d, 2H, J = 7.2 Hz). 13C NMR (CDCl3): δ 153.6,
153.1, 151.0, 138.8, 138.3, 135.0, 129.8, 129.3, 127.4, 127.2, 125.9,
121.1, 120.9, 118.7, 83.8, 69.9, 66.9, 24.5. MS (MS ES+, m/z): (M +
+
NH4 ), 521.3. HRMS (TOF MS ES+, m/z): calcd for C28H34BN2O7
+
(M + NH4 ): 521.2459, found 521.2465.
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl 4-
((Methoxycarbonyloxy)methyl)phenylcarbamate (10). To a round-
bottom flask was added 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzyl 4-(hydroxymethyl)phenylcarbamate (46; 0.83 g, 2.2 mmol, 1
equiv), dichloromethane (22 mL), N,N-diisopropylethylamine (0.60
mL, 3.4 mmol, 1.5 equiv), methyl chloroformate (0.25 mL, 3.3 mmol,
1.5 equiv), and 4-(dimethylamino)pyridine (26 mg, 0.22 mmol, 0.10
equiv). The solution was stirred at 25 °C for 12 h. The resulting
mixture was diluted using saturated aqueous ammonium chloride
solution (20 mL), and the aqueous layer was extracted using
dichloromethane (2 × 20 mL). The organic layers were combined
and were dried over sodium sulfate. The sodium sulfate was removed
by filtration, and the resulting solution was concentrated by rotary
evaporation. The residue was purified using silica gel flash column
chromatography (20% ethyl acetate in hexanes, increasing to 40%
ethyl acetate) to afford 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzyl 4-((methoxycarbonyloxy)methyl)phenylcarbamate (10; 0.24
g, 0.48 mmol, 92%) as a white solid. Mp: 96−98 °C. IR (cm−1): 3350,
1
without further purification; therefore, a yield is not reported. The H
NMR and 13C NMR spectra likely contain signals for rotamers, as was
observed for compound 26. The spectra also contain signals for
diastereomers. Mp: 138 °C dec. IR (cm−1): 3296, 2919, 2359, 2338,
1593, 1510. 1H NMR (CD3OD): δ 0.85−0.92 (m, 3H), 1.15−2.05 (m,
13H), 2.85 (t, 2H, J = 6.1 Hz), 3.2−3.75 (m, 12H), 4.92−5.13 (m,
4H), 5.40 (s, 1H), 7.04−7.30 (m, 9H), 7.30−7.40 (m, 4H). 13C NMR
(CD3OD): δ 179.1, 175.1, 157.8, 154.5, 139.2, 138.9, 133.2, 130.6,
130.5, 129.3, 128.7, 127.9, 126.9, 125.8, 124.4, 117.9, 116.5, 101.4,
101.0, 76.7, 75.3, 73.4, 72.2, 67.5, 66.0, 65.9, 63.4, 63.3, 36.8, 36.7,
36.3, 35.9, 29.2, 29.1, 25.0, 24.5, 22.8, 18.7, 18.6, 16.4. MS (MS ES-,
m/z): (M − H)−, 706.3. HRMS (TOF MS ES+, m/z): calcd for
C39H49NO11Li (M + Li)+ 714.3466, found 714.3472.
1
2972, 2358, 1714, 1610, 1532. H NMR (CDCl3): δ 1.34 (s, 12H),
3.76 (s, 3H), 5.08 (s, 2H), 5.16 (s, 2H), 7.19 (s, 1H), 7.27−7.40 (m,
6H), 7.79 (d, 2H, J = 8.1 Hz). 13C NMR (CDCl3): δ 156.2, 153.8,
139.5, 138.7, 135.5, 130.6, 129.9, 127.8, 119.1, 84.4, 69.9, 69.8, 67.3,
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl 4-
(Hydroxymethyl)phenylcarbamate (46). To a round-bottom flask
was added 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl 4-
formylphenylcarbamate (8; 1.3 g, 3.3 mmol, 1 equiv), dichloro-
methane (16 mL), and methanol (16 mL). The mixture was cooled to
+
55.3, 25.3. MS (TOF MS ES+, m/z): (M + NH4 ), 459.2. HRMS
(TOF MS ES+, m/z): calcd for C23H32BN2O7 (M + NH4+) 459.2303,
found 459.2294.
10110
dx.doi.org/10.1021/jo2018763 | J. Org. Chem. 2011, 76, 10099−10113